Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. Br J Cancer. 2014 Jun 10; 110(12):2896-904.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.